From the moment in 2008 when Andrew Witty took control of London-based GlaxoSmithKline , a pharmaceutical giant with $42 billion in annual sales, he has seemed intent on repairing the reputation of the drug industry – and undoing the damage done to his own firm’s reputation by the controversy over diabetes pill Avandia, which critics said caused heart attacks. Matinee-idol handsome and athletic, Witty lacked the imperious and angry manner that marked his predecessor, Jean-Pierre Garnier, or the sharp-edge Henry McKinnell, who ran Pfizer PFE +1.53% in the early 2000s.
Hey, check out all the research scientist jobs. Post your resume today!
